NewsBenzingaBTIG mantiene su recomendación de compra sobre AtriCure y eleva el precio objetivo a 70 dólares BTIG mantiene su recomendación de compra sobre AtriCure y eleva el precio objetivo a 70 dólares Benzinga 2026.11.04 10:04 (GMT+0) Open on Benzinga Other news Nvidia Shares Rise After Earnings Beat in First Report Since Jensen Huang's Exit NVIDIA Chairman Harvey Jones: Board Has No Intention of Restoring Jensen Huang as CEO Slower Retail Sales Drag on Market SEC reportedly investigating Nvidia amid Huang exit A $3 Billion Reason Why Disney Stock Is in Focus Today Google joins the tech outage trend by announcing it’s not having one